Search research articles
Contact Us
Filters
Showing results (191-200 of 265) with videos related to
Page
of 27
Sort By:
JCO Precision Oncology
|
February 1, 2022
Validation of <i>HER2</i> Amplification as a Predictive Biomarker for Anti-Epidermal Growth Factor Receptor Antibody Therapy in Metastatic Colorectal Cancer
Kanwal Raghav, Jonathan M Loree, Jeffrey S Morris, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 12, 2023
Endoscopic and imaging outcomes of PD-1 therapy in localised dMMR colorectal cancer
Daniel A Fox, Deepak Bhamidipati, Tsuyoshi Konishi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2021
ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer
Amir Mehrvarz Sarshekeh, Jumanah Alshenaifi, Jason Roszik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 22, 2008
Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases
Dan G Blazer, Yoji Kishi, Dipen M Maru, et al.
JCO Precision Oncology
|
July 12, 2021
Comprehensive Clinical and Molecular Characterization of <i>KRAS</i> <sup>G12C</sup>-Mutant Colorectal Cancer
Jason T Henry, Oluwadara Coker, Saikat Chowdhury, et al.
Annals of Surgical Oncology
|
December 10, 2025
Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II Trial
Ian W Folkert, Reza Mehran, Ryan Sun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2015
Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
M P Morelli, M J Overman, A Dasari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2016
Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials
M J Overman, V Morris, B Kee, et al.
Plos One
|
March 8, 2017
Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer
Amir Mehrvarz Sarshekeh, Shailesh Advani, Michael J Overman, et al.
Science Translational Medicine
|
August 10, 2022
Adenoviral-based vaccine promotes neoantigen-specific CD8<sup>+</sup> T cell stemness and tumor rejection
Anna Morena D'Alise, Nadia Brasu, Carlo De Intinis, et al.
Page
of 27
Search research articles
Search
Showing results (191-200 of 265) with videos related to
Sort By:
Page
of 27
JCO Precision Oncology
|
February 1, 2022
Validation of <i>HER2</i> Amplification as a Predictive Biomarker for Anti-Epidermal Growth Factor Receptor Antibody Therapy in Metastatic Colorectal Cancer
Kanwal Raghav, Jonathan M Loree, Jeffrey S Morris, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 12, 2023
Endoscopic and imaging outcomes of PD-1 therapy in localised dMMR colorectal cancer
Daniel A Fox, Deepak Bhamidipati, Tsuyoshi Konishi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2021
ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer
Amir Mehrvarz Sarshekeh, Jumanah Alshenaifi, Jason Roszik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 22, 2008
Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases
Dan G Blazer, Yoji Kishi, Dipen M Maru, et al.
JCO Precision Oncology
|
July 12, 2021
Comprehensive Clinical and Molecular Characterization of <i>KRAS</i> <sup>G12C</sup>-Mutant Colorectal Cancer
Jason T Henry, Oluwadara Coker, Saikat Chowdhury, et al.
Annals of Surgical Oncology
|
December 10, 2025
Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II Trial
Ian W Folkert, Reza Mehran, Ryan Sun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2015
Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
M P Morelli, M J Overman, A Dasari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2016
Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials
M J Overman, V Morris, B Kee, et al.
Plos One
|
March 8, 2017
Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer
Amir Mehrvarz Sarshekeh, Shailesh Advani, Michael J Overman, et al.
Science Translational Medicine
|
August 10, 2022
Adenoviral-based vaccine promotes neoantigen-specific CD8<sup>+</sup> T cell stemness and tumor rejection
Anna Morena D'Alise, Nadia Brasu, Carlo De Intinis, et al.
Page
of 27